睡前使用电子屏幕已成为现代人的普遍生活方式。一项涵盖逾12.2万名成年人的调查显示，41%的受访者每晚睡前一小时内都会使用屏幕设备，仅有17%的人完全不接触屏幕。这种睡前习惯常与睡眠质量下降相关联，而屏幕发出的“蓝光”通常被视为罪魁祸首，并催生了庞大的防蓝光眼镜、过滤贴膜和软件市场。然而，严格的科学实证研究表明，将睡眠障碍简单归咎于蓝光的流行观点缺乏坚实的实验证据支持。
从生理机制来看，人眼视网膜中的非视觉细胞含有视黑素（melanopsin），它对波长约480纳米的蓝光最为敏感，并向大脑生物钟神经元传递信号以抑制褪黑素（melatonin）分泌。尽管蓝光在生物学上确实能阻碍褪黑素生成，但日常屏幕暴露的实际生理影响被严重夸大。2015年发表于《美国国家科学院院刊》（PNAS）的一项经典研究显示，受试者在暗室中连续阅读电子屏长达4小时后褪黑素水平下降约50%，但其入睡延迟时间平均仅增加了微不足道的10分钟；而2016年一项将阅读缩短至2小时的研究更发现，两组受试者在褪黑素水平与睡眠质量上毫无统计学差异。
针对蓝光防护产品的实证检验同样表明其功效存疑。2023年考克兰协作网（Cochrane）系统性评估了17项关于防蓝光镜片的临床试验，未发现其对改善睡眠具有明确效益，各类屏幕滤蓝光软件的效果同样尚无定论。牛津大学昼夜节律神经学家拉塞尔·福斯特（Russell Foster）强调，决定睡前清醒度与昼夜节律重塑的核心因素是整体光照强度（brightness）而非特定光谱颜色。任何明亮的室内白光均会刺激中枢神经，因此改善睡眠的科学策略是降低就寝前的整体环境照度，而非盲目寄望于过滤蓝光。
Pre-sleep engagement with digital screens has become ubiquitous, with a 2025 survey of 122,058 adults revealing that 41% engage with electronic displays during the hour before bed and only 17% abstain entirely. Widespread public conviction holds that high-energy shortwave blue light emitted by consumer electronics severely disrupts nocturnal sleep architecture, driving a commercial boom in blue-filtering eyewear, software, and physical screen overlays. However, rigorous clinical neuroscience increasingly indicates that popular apprehensions regarding blue spectrum wavelengths are largely disproportionate to real-world physiological impacts.
The underlying biological pathway involves intrinsically photosensitive retinal ganglion cells containing the photopigment melanopsin, which regulates circadian pace by signalling suprachiasmatic hypothalamic neurons to suppress sleep-inducing melatonin. Although melanopsin exhibits peak sensitivity near 480 nanometres within the blue spectrum, empirical studies demonstrate that domestic screen exposure exerts minimal functional impact on sleep latency. A 2015 study in the Proceedings of the National Academy of Sciences found that while four uninterrupted hours of reading tablets reduced evening melatonin by roughly 50%, it delayed actual sleep onset by an average of merely ten minutes. Furthermore, a 2016 study in Sleep Medicine replicating typical two-hour exposures found zero statistically significant differences in melatonin secretion or total sleep duration.
Evidence supporting commercial intervention remains similarly insubstantial. A comprehensive 2023 Cochrane systematic review of 17 randomised controlled trials concluded that blue-blocking lenses provide no measurable improvement in sleep quality or onset metrics, while evidence regarding blue-filtering software presets remains thoroughly inconclusive. Oxford University neuroscientist Russell Foster highlights that overall illuminance and luminance intensity—rather than spectral blueness—dictate neurological alertness and circadian entrainment. Consequently, clinical recommendations should emphasize moderating total ambient light exposure and cognitive stimulation before bedtime rather than relying on commercial blue-light mitigation accessories.
Source: Should you avoid blue light before bed?
Subtitle: Blueness may be less important than brightness
Dateline: Sep 10th 2026